ANDA 76584, held by Rising. Alendronate Sodium.
As of Nov 16, 2026, ANDA 76584 (Alendronate Sodium), held by Rising, was first approved by FDA on Aug 4, 2008, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 4, 2008 | Original application | Approved | None posted |
| Alendronate SodiumEQ 5MG BASE · tablet;oral | Alendronate Sodium | Discontinued |
| Alendronate SodiumEQ 10MG BASE · tablet;oral | Alendronate Sodium | Discontinued |
| Alendronate SodiumEQ 35MG BASE · tablet;oral | Alendronate Sodium | Discontinued |
| Alendronate SodiumEQ 70MG BASE · tablet;oral | Alendronate Sodium | Discontinued |
| Jun 8, 2026 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jan 31, 2023 | Supplement 16Labeling · Standard review | Approved | None posted |
| Apr 8, 2016 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jul 16, 2015 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jul 16, 2015 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jul 18, 2013 | Supplement 9Manufacturing | Approved | None posted |
| Oct 17, 2012 | Supplement 11Labeling · Standard review | Approved | None posted |
| May 4, 2011 | Supplement 5Labeling | Approved | None posted |
| May 2, 2011 | Supplement 7Labeling | Approved | None posted |
| Nov 20, 2009 | Supplement 3Labeling | Approved | None posted |
| Aug 4, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters